I run an AI model capturing 98 economic indicators monitoring chances of Recession. Daily monitoring and adjustments. Today, the risk moved up to 63.3% chance of recession. #recession
Through the use of A.I.'s Claude, I compiled a multitude of variables and estimated the risk of a recession. As of today, April 14th, my model is showing a 71% chance of a US Recession: https://t.co/xcu9Q4nGgE
$IBIO Many major companies arguably have been detrimental to society (eg, obesity, digital addiction). These companies and their stocks are booming (think coca cola).
Meanwhile iBio quietly paves the way for a brighter society.
We’re on the right side of history.
Phoenix population is skyrocketing yet it will be unimaginably uninhabited in 30-50 years.
Everyone knows or has been warned about this alarming future. But will resident flee?
July 3rd. 2023 was recorded as hottest day ever. If climate change is a real and grave concern, why wouldn’t people adopt an accepting attitude of if?
A sort of cognitive dissonance?
#political#climate
$IBIO Our averages are high, yes. And so you need to buy more to (dare I say) average down.
Make no mistake- this is a penny stock. Don’t assume it should be anything different.
And this is a long term hold. So don’t b... https://t.co/Nd02Z4D0ju
$IBIO iBio just leveled up. Why?
Take RubrYc's deal. RubrYc is A.I. generation "computational biology" which looks to trigger the best epitope response. What does this mean? Lets run a smart machine to determine what t... https://t.co/Zg3aRQlcRq
$IBIO Buffet told Berkshire/Hathway that his investment strategy is “lethargy bordering on sloth.”
Look for the easy long term wins based on the research. And then sit back.
Embrace your inner sloth!
🦥
$IBIO iBio's release did a few things:
1) Confirmed continued development of 202
2) Outlined the exact point of its development (challenge study)
3) Put a lot of emphasis on funding
There is ZERO bearishness about this PR. The market will reflect this in the share price.
$IBIO Journal of Nature is reporting the rising costs (1.3billion) to see drug to fruition. iBio is banging the "we're cheaper" drug. This is a good bet. A really good bet. Go iBio, Go!
$IBIO Assuming that monkey pox is iBio savior 2.0 is probably a false hope. But for those curious, yes- ibio could manufacture monkey pox vaccines (e.g. subunit proteins).
And dare I bang raise the topic again that everyo... https://t.co/FIxlJxvkRl
$IBIO Look at their pipeline, number of employees, market outlook, facility and a host of other factors. The RS option left a bad taste in people’s mouths and overlooked the capabilities of this huge factory + lab. It’s a ... https://t.co/MbW5ea6gTP